Increasing PrEP uptake and adherence among MSM and TW sex workers in Lima, Perú: what and whom do different patients trust?

References

• Baeten, J. M., Donnell, D., Ndase, P., Mugo, N. R., Campbell, J. D., Wangisi, J., … Celum, C. (2012). Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. New England Journal of Medicine, 367(5), 399–410. doi: 10.1056/NEJMoa1108524
   PubMed Web of Science ®Google Scholar
• Bayer, A. M., Garvich, M., Díaz, D. A., Sánchez, H., García, P. J., & Coates, T. J. (2014). “Just getting by”: A cross-sectional study of male sex workers as a most-at-risk population for HIV/STIs among men who have sex with men in Peru. Sexually Transmitted Infections, 90(3), 223–229. doi: 10.1136/sextrans-2013-051265
   PubMed Web of Science ®Google Scholar
• Cahill, S., Taylor, S. W., Elsesser, S. A., Mena, L., Hickson, D., & Mayer, K. H. (2017). Stigma, medical mistrust, and perceived racism may affect PrEP awareness and uptake in black compared to white gay and bisexual men in jackson, Mississippi and Boston, Massachusetts. AIDS Care, 29(11), 1351–1358. doi: 10.1080/09540121.2017.1300633
   PubMed Web of Science ®Google Scholar
• Castillo, R., Konda, K., Leon, S., Silva-Santisteban, A., Salazar, X., Klausner, J., . . . Cáceres, C. (n.d.). HIV and Sexually Transmitted Infection Incidence and Associated Risk Factors Among High-Risk MSM and Male-to-Female Transgender Women in Lima, Peru. Journal of Acquired Immune Deficiency Syndromes : JAIDS., 69(5), 567-575.
   Google Scholar
• Cáceres, C., & Mendoza, W. (n.d.). The national response to the HIV/AIDS epidemic in Peru: Accomplishments and gaps--a review. Journal of Acquired Immune Deficiency Syndromes : JAIDS., 51 Suppl 1, S60-S66.
   Google Scholar
• Choopanya, K., Martin, M., Suntharasamai, P., Sangkum, U., Mock, P. A., Leethochawalit, M., … Bangkok Tenofovir Study Group. (2013). Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok tenofovir study): A randomised, double-blind, placebo-controlled phase 3 trial. Lancet (London, England), 381(9883), 2083–2090. doi: 10.1016/S0140-6736(13)61127-7
   PubMed Web of Science ®Google Scholar
• Deutsch, M. B., Glidden, D. V., Sevelius, J., Keatley, J., McMahan, V., Guanira, J., … Grant, R. M. (2015). HIV pre-exposure prophylaxis in transgender women: A subgroup analysis of the iPrEx trial. The Lancet HIV, 2(12), e519. doi: 10.1016/S2352-3018(15)00206-4
   Web of Science ®Google Scholar
• Galea, J. T., Kinsler, J. J., Salazar, X., Lee, S. J., Giron, M., Sayles, J. N., … Cunningham, W. E. (2011). Acceptability of pre-exposure prophylaxis as an HIV prevention strategy: Barriers and facilitators to pre-exposure prophylaxis uptake among at-risk Peruvian populations. International Journal of STD & AIDS, 22(5), 256–262. doi: 10.1258/ijsa.2009.009255
   PubMed Web of Science ®Google Scholar
• García, M., & Harris, A. L. (2017). PrEP awareness and decision-making for latino MSM in san antonio, texas. Plos One, 12(9), e0184014. doi: 10.1371/journal.pone.0184014
   PubMed Web of Science ®Google Scholar
• Giovanni, R., Beatriz, G., Ricardo, B., Guanira, J. V., Ricardo, L., Cáceres Carlos, F., & Massimo, G. (2016). Towards a fair consideration of PrEP as part of combination HIV prevention in latin america. Journal of the International AIDS Society, 19(7), 21113. doi: 10.7448/IAS.19.7.21113
   PubMedGoogle Scholar
• Goicochea, P., & Montoya, O. (2014). Implementing Biomedical HIV Prevention Advances in Ecuador and Peru, doi: 10.1007/978-1-4614-8845-3_12
   Google Scholar
• Grant, R. M., Lama, J. R., Anderson, P. L., McMahan, V., Liu, A. Y., Vargas, L., … Glidden, D. V. (2010). Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. New England Journal of Medicine, 363(27), 2587–2599. doi: 10.1056/NEJMoa1011205
   PubMed Web of Science ®Google Scholar
• Hsieh, H. F., & Shannon, S. E. (2005). Three approaches to qualitative content analysis. Qualitative Health Research, 15(9), 1277–1288. doi:15/9/1277 [pii] doi: 10.1177/1049732305276687
   PubMed Web of Science ®Google Scholar
• Lee, S. W., Deiss, R. G., Segura, E. R., Clark, J. L., Lake, J. E., Konda, K. A., … Caceres, C. F. (2015). A cross-sectional study of low HIV testing frequency and high-risk behaviour among men who have sex with men and transgender women in Lima, Peru. BMC Public Health, 15(408), doi: 10.1186/s12889-015-1730-5
   Google Scholar
• Lemmens, T., & Vacaflor, C. H. (2018). Clinical trial transparency in the americas: The need to coordinate regulatory spheres. Bmj, 362(k2493), doi: 10.1136/bmj.k2493
   PubMedGoogle Scholar
• Lippman, S. A., Koester, K. A., Amico, K. R., Lama, J. R., Martinez Fernandes, N., Gonzales, P., … Koblin, B. A. (2015). Client and provider perspectives on new HIV prevention tools for MSM in the americas. PloS One, 10(3), e0121044. doi: 10.1371/journal.pone.0121044
   PubMed Web of Science ®Google Scholar
• Liu, A., Glidden, D. V., Anderson, P. L., Amico, K. R., McMahan, V., Mehrotra, M., … iPrEx Study team. (2014). Patterns and correlates of PrEP drug detection among MSM and transgender women in the global iPrEx study. Journal of Acquired Immune Deficiency Syndromes (1999), 67(5), 528–537. doi: 10.1097/QAI.0000000000000351
   PubMed Web of Science ®Google Scholar
• Marrazzo, J. M., Ramjee, G., Richardson, B. A., Gomez, K., Mgodi, N., Nair, G., … VOICE Study Team. (2015). Tenofovir-based preexposure prophylaxis for HIV infection among african women. The New England Journal of Medicine, 372(6), 509–518. doi: 10.1056/NEJMoa1402269
   PubMed Web of Science ®Google Scholar
• Minaya, G. E., Fuentes-Delgado, D., Ugalde, A., & Homedes, N. (2017). A missing piece in clinical trial inspections in latin america: Interviews with research subjects in Peru. Journal of Empirical Research on Human Research Ethics, 12(4), 232–245. doi: 10.1177/1556264617720756
   PubMed Web of Science ®Google Scholar
• Mujica, J. (2013). The microeconomics of sexual exploitation of girls and young women in the Peruvian Amazon. Culture, Health & Sexuality, 15, S152. doi: 10.1080/13691058.2013.797606
   Web of Science ®Google Scholar
• Pun, M. (2015). Situacion de la epidemia de VIH en peru. (). Lima, Peru: Red Nacional de Epidemiologia. Retrieved from https://web.kamihq.com/web/viewer.html?source=extension_pdfhandler&file=https%3A%2F%2Fwww.minsa.gob.pe%2Fportada%2FEspeciales%2F2015%2Fvih%2Fmatcom%2FSituacion-Epidemiologica-VIH-2015.pdf
   Google Scholar
• Reisner, S. L., Perez-Brumer, A. G., McLean, S. A., Lama, J. R., Silva-Santisteban, A., Huerta, L., … Mayer, K. H. (2017). Perceived barriers and facilitators to integrating HIV prevention and treatment with cross-sex hormone therapy for transgender women in Lima, Peru. AIDS and Behavior, 21(12), 3299–3311. doi: 10.1007/s10461-017-1768-8
   PubMed Web of Science ®Google Scholar
• Salazar, X., Núnez-Curto, A., Villayzán, J., Castillo, R., Benites, C., Caballero, P., & Cáceres, C. F. (2016). How Peru introduced a plan for comprehensive HIV prevention and care for transwomen. Journal of the International AIDS Society, 19(3), 20790. doi: 10.7448/IAS.19.3.20790
   PubMedGoogle Scholar
• Sanchez, Jorge, Lama, Javier R, Kusunoki, Lourdes, Manrique, Hugo, Goicochea, Pedro, Lucchetti, Aldo, . . . Celum, Connie. (n.d.). HIV-1, sexually transmitted infections, and sexual behavior trends among men who have sex with men in Lima, Peru. Journal of Acquired Immune Deficiency Syndromes : JAIDS., 44(5), 578-585.
   Google Scholar
• Sevelius, J. M., Keatley, J., Calma, N., & Arnold, E. (2016). ‘I am not a man’: Trans-specific barriers and facilitators to PrEP acceptability among transgender women. Global Public Health, 11(7-8), 1060–1075. doi: 10.1080/17441692.2016.1154085
   PubMed Web of Science ®Google Scholar
• Silva-Santisteban, A., Raymond, H. F., Salazar, X., Villayzan, J., Leon, S., McFarland, W., & Caceres, C. F. (2012). Understanding the HIV/AIDS epidemic in transgender women of Lima, Peru: Results from a sero-epidemiologic study using respondent driven sampling. AIDS and Behavior, 16(4), 872–881. doi: 10.1007/s10461-011-0053-5
   PubMed Web of Science ®Google Scholar
• Tabet, S., Sanchez, J., Lama, J., Goicochea, P., Campos, P., Rouillon, M., . . . Holmes, K. (n.d.). HIV, syphilis and heterosexual bridging among Peruvian men who have sex with men. AIDS., 16(9), 1271-1277.
   Google Scholar
• Thigpen, M. C., Kebaabetswe, P. M., Paxton, L. A., Smith, D. K., Rose, C. E., Segolodi, T. M., … Brooks, J. T. (2012). Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. New England Journal of Medicine, 367(5), 423–434. doi: 10.1056/NEJMoa1110711
   PubMed Web of Science ®Google Scholar
• Underhill, K., Morrow, K. M., Colleran, C., Calabrese, S. K., Operario, D., Salovey, P., & Mayer, K. H. (2016). Explaining the efficacy of pre-exposure prophylaxis (PrEP) for HIV prevention: A qualitative study of message framing and messaging preferences among US men who have sex with men. AIDS and Behavior, 20(7), 1514–1526. doi: 10.1007/s10461-015-1088-9
   PubMed Web of Science ®Google Scholar
• US Department of State. (2010). Peru: Reports on human rights practices report march 11, 2010. Retrieved from https://www.state.gov/j/drl/rls/hrrpt/2009/wha/136123.htm
   Google Scholar
• Van Damme, L., Corneli, A., Ahmed, K., Agot, K., Lombaard, J., Kapiga, S., … FEM-PrEP Study Group. (2012). Preexposure prophylaxis for HIV infection among african women. The New England Journal of Medicine, 367(5), 411–422. doi: 10.1056/NEJMoa1202614
   PubMed Web of Science ®Google Scholar
• Yi, S., Tuot, S., Mwai, G. W., Ngin, C., Chhim, K., Pal, K., … Mburu, G. (2017). Awareness and willingness to use HIV pre-exposure prophylaxis among men who have sex with men in low- and middle-income countries: A systematic review and meta-analysis. Journal of the International AIDS Society, 20(1), 21580. doi: 10.7448/IAS.20.1.21580
   PubMed Web of Science ®Google Scholar